This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): p2TA
Description: AB103 is a CD28 co-stimulatory receptor antagonist that offers a unique approach in the treatment of infectious diseases by modulating but not inhibiting the host immune system.
Additional information available to subscribers only: